XML 115 R90.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Related Parties - Restricted Stock Program (Detail) - 12 months ended Dec. 31, 2023 R$ / shares in Units, R$ in Thousands | BRL (R$) shares R$ / shares | $ / shares
--- | --- | ---
Disclosure of transactions between related parties [line items] |  |
Number of shares granted (Quantity) | shares | 14,834,595 |
Total exercisable grant costs, including taxes | R$ 433,901 |
Accumulated recognized exercisable grant costs | (124,841) |
Unrecognized exercisable grant costs (in R$ thousands) | R$ 309,060 |
Restricted Stock Award [Member] | Grant Date, September 19, 2018 [Member] |  |
Disclosure of transactions between related parties [line items] |  |
Grant date | September 19, 2018 |
Number of shares granted (Quantity) | shares | 80,000 |
Vesting period | 2024 |
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 19.58 |
Total exercisable grant costs, including taxes | R$ 2,675 |
Accumulated recognized exercisable grant costs | (2,341) |
Unrecognized exercisable grant costs (in R$ thousands) | R$ 334 |
Restricted Stock Award [Member] | Grant Date, April 3, 2019 [Member] |  |
Disclosure of transactions between related parties [line items] |  |
Grant date | April 3, 2019 |
Number of shares granted (Quantity) | shares | 25,996 |
Vesting period | 2024 |
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 23.25 |
Total exercisable grant costs, including taxes | R$ 3,083 |
Accumulated recognized exercisable grant costs | (3,027) |
Unrecognized exercisable grant costs (in R$ thousands) | R$ 56 |
Restricted Stock Award [Member] | Grant Date, September 2, 2019 [Member] |  |
Disclosure of transactions between related parties [line items] |  |
Grant date | September 2, 2019 |
Number of shares granted (Quantity) | shares | 240,000 |
Vesting period | 2025 |
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 16.42 |
Total exercisable grant costs, including taxes | R$ 6,756 |
Accumulated recognized exercisable grant costs | (4,880) |
Unrecognized exercisable grant costs (in R$ thousands) | R$ 1,876 |
Restricted Stock Award [Member] | Grant Date, April 1, 2020 [Member] |  |
Disclosure of transactions between related parties [line items] |  |
Grant date | April 1, 2020 |
Number of shares granted (Quantity) | shares | 89,388 |
Vesting period | 2024 to 2025 |
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 12.53 |
Total exercisable grant costs, including taxes | R$ 2,107 |
Accumulated recognized exercisable grant costs | (1,781) |
Unrecognized exercisable grant costs (in R$ thousands) | R$ 326 |
Restricted Stock Award [Member] | Grant Date, September 16, 2020 [Member] |  |
Disclosure of transactions between related parties [line items] |  |
Grant date | September 16, 2020 |
Number of shares granted (Quantity) | shares | 140,000 |
Vesting period | 2026 |
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 23.03 |
Total exercisable grant costs, including taxes | R$ 5,464 |
Accumulated recognized exercisable grant costs | (3,036) |
Unrecognized exercisable grant costs (in R$ thousands) | R$ 2,428 |
Restricted Stock Award [Member] | Grant Date, April 7, 2021 [Member] |  |
Disclosure of transactions between related parties [line items] |  |
Grant date | April 7, 2021 |
Number of shares granted (Quantity) | shares | 339,678 |
Vesting period | 2024 |
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 21 |
Total exercisable grant costs, including taxes | R$ 13,822 |
Accumulated recognized exercisable grant costs | (12,711) |
Unrecognized exercisable grant costs (in R$ thousands) | R$ 1,111 |
Restricted Stock Award [Member] | Grant Date, September 22, 2021 [Member] |  |
Disclosure of transactions between related parties [line items] |  |
Grant date | September 22, 2021 |
Number of shares granted (Quantity) | shares | 1,000,000 |
Vesting period | 2027 |
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 14.17 |
Total exercisable grant costs, including taxes | R$ 24,363 |
Accumulated recognized exercisable grant costs | (9,576) |
Unrecognized exercisable grant costs (in R$ thousands) | R$ 14,787 |
Restricted Stock Award [Member] | Grant Date, April 6, 2022 [Member] |  |
Disclosure of transactions between related parties [line items] |  |
Grant date | April 6, 2022 |
Number of shares granted (Quantity) | shares | 667,194 |
Vesting period | 2025 |
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 14.16 |
Total exercisable grant costs, including taxes | R$ 18,240 |
Accumulated recognized exercisable grant costs | (10,885) |
Unrecognized exercisable grant costs (in R$ thousands) | R$ 7,355 |
Restricted Stock Award [Member] | Grant Date, September 21, 2022 [Member] |  |
Disclosure of transactions between related parties [line items] |  |
Grant date | September 21, 2022 |
Number of shares granted (Quantity) | shares | 2,640,000 |
Vesting period | 2032 |
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 12.98 |
Total exercisable grant costs, including taxes | R$ 64,048 |
Accumulated recognized exercisable grant costs | (8,540) |
Unrecognized exercisable grant costs (in R$ thousands) | R$ 55,508 |
Restricted Stock Award [Member] | Grant Date, December 7, 2022 [Member] |  |
Disclosure of transactions between related parties [line items] |  |
Grant date | December 7, 2022 |
Number of shares granted (Quantity) | shares | 1,500,000 |
Vesting period | 2032 |
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 13.47 |
Total exercisable grant costs, including taxes | R$ 37,711 |
Accumulated recognized exercisable grant costs | (4,090) |
Unrecognized exercisable grant costs (in R$ thousands) | R$ 33,621 |
Restricted Stock Award [Member] | Grant Date, April 20, 2023 [Member] |  |
Disclosure of transactions between related parties [line items] |  |
Grant date | April 20, 2023 |
Number of shares granted (Quantity) | shares | 311,324 |
Vesting period | 2025 |
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 14.5 |
Total exercisable grant costs, including taxes | R$ 7,472 |
Accumulated recognized exercisable grant costs | (2,802) |
Unrecognized exercisable grant costs (in R$ thousands) | R$ 4,670 |
Restricted Stock Award [Member] | Grant Date, April 20, 2023 [Member] |  |
Disclosure of transactions between related parties [line items] |  |
Grant date | April 20, 2023 |
Number of shares granted (Quantity) | shares | 1,179,409 |
Vesting period | 2026 |
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 14.5 |
Total exercisable grant costs, including taxes | R$ 32,040 |
Accumulated recognized exercisable grant costs | (8,129) |
Unrecognized exercisable grant costs (in R$ thousands) | R$ 23,911 |
Restricted Stock Award [Member] | Grant Date, September 20, 2023 [Member] |  |
Disclosure of transactions between related parties [line items] |  |
Grant date | September 20, 2023 |
Number of shares granted (Quantity) | shares | 3,800,000 |
Vesting period | 2033 |
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 18.75 |
Total exercisable grant costs, including taxes | R$ 132,775 |
Accumulated recognized exercisable grant costs | (4,426) |
Unrecognized exercisable grant costs (in R$ thousands) | R$ 128,349 |
Performance Stock Award [Member] | Grant Date, April 1, 2020 [Member] |  |
Disclosure of transactions between related parties [line items] |  |
Grant date | April 1, 2020 |
Number of shares granted (Quantity) | shares | 144,202 |
Vesting period | 2024 to 2025 |
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 12.53 |
Total exercisable grant costs, including taxes | R$ 3,234 |
Accumulated recognized exercisable grant costs | (2,845) |
Unrecognized exercisable grant costs (in R$ thousands) | R$ 389 |
Performance Stock Award [Member] | Grant Date, April 7, 2021 [Member] |  |
Disclosure of transactions between related parties [line items] |  |
Grant date | April 7, 2021 |
Number of shares granted (Quantity) | shares | 645,094 |
Vesting period | 2024 |
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 21 |
Total exercisable grant costs, including taxes | R$ 25,358 |
Accumulated recognized exercisable grant costs | (23,692) |
Unrecognized exercisable grant costs (in R$ thousands) | R$ 1,666 |
Performance Stock Award [Member] | Grant Date, April 6, 2022 [Member] |  |
Disclosure of transactions between related parties [line items] |  |
Grant date | April 6, 2022 |
Number of shares granted (Quantity) | shares | 847,990 |
Vesting period | 2025 |
Fair value of shares on the grant date (in R$ per share) | R$ / shares | R$ 14.16 |
Total exercisable grant costs, including taxes | R$ 22,694 |
Accumulated recognized exercisable grant costs | (13,931) |
Unrecognized exercisable grant costs (in R$ thousands) | R$ 8,763 |
Performance Stock Award [Member] | Grant Date, April 20, 2023 [Member] |  |
Disclosure of transactions between related parties [line items] |  |
Grant date | April 20, 2023 |
Number of shares granted (Quantity) | shares | 1,184,320 |
Vesting period | 2026 |
Fair value of shares on the grant date (in R$ per share) | $ / shares |  | $ 14.5
Total exercisable grant costs, including taxes | R$ 32,059 |
Accumulated recognized exercisable grant costs | (8,149) |
Unrecognized exercisable grant costs (in R$ thousands) | R$ 23,910 |

X
- Definition The date on which share-based payment arrangements are granted. [Refer: Share-based payment arrangements [member]] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 45 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_a&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph IG23 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_IG23&doctype=Implementation%20Guidance -URIDate 2023-03-23 + Details
Name: | ifrs-full_DateOfGrantOfSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 45 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_a&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 51 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_51_a&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard -URIDate 2023-03-23 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 47 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of accumulated recognized grant costs arising from share-based payment transactions. + References No definition available. + Details
Name: | ugp_AccumulatedRecognizedExercisableGrantCosts
Namespace Prefix: | ugp_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of accumulated unrecognized grant costs arising from share-based payment transactions. + References No definition available. + Details
Name: | ugp_AccumulatedUnrecognizedExercisableGrantCosts
Namespace Prefix: | ugp_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ugp_SharebasedPaymentPlanNameAxis=ugp_RestrictedStockAwardMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember192018Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateApril32019Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember22019Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateApril12020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember162020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateApril72021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember222021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateApril62022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember212022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateDecember72022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateApril202023OneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateApril202023TwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember202023Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ugp_SharebasedPaymentPlanNameAxis=ugp_PerformanceStockAwardMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |